Week of November 1, 2021

This episode discusses two MMWR reports. The first highlights ACIP's interim recommendation for the use of the Pfizer-BioNTech COVID-19 Vaccine in children ages 5-11 years. And the second looks at the effectiveness of mRNA vaccination among immunocompromised and immunocompetent adults.